Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

Next predicted deadline: Oct 16, 2023

Later predicted deadlines: Feb 16, 2024, Jun 16, 2024

Grant amount: Up to US $125,000

Funding uses: Research

Location of project: Anywhere in the world

Location of residency: United States, American Samoa, Guam, Northern Mariana Islands, Puerto Rico, Virgin Islands Show all

Overview:

NOTE: All applications are due by 5:00 PM local time of the applicant organization. 

The purpose of this Funding Opportunity Announcement (FOA) is to provide support for new investigators from diverse backgrounds, including from groups nationally underrepresented in biomedical research, to conduct small research projects in the scientific mission areas of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and participating Institutes and Centers. New investigagetors at the time of award under this FOA will have/have had less than $125,000 direct costs of combined research funding (excluding NIH training and NIH career awards). This R21 will support small research projects that can be carried out in a short period of time with limited resources and seeks to facilitate transition to research independence. The R21 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.